**The big picture:** Walmart is significantly enhancing its employee benefits package for 2027, introducing no-cost coverage for over 250 prescription drugs, expanded specialist care access, and increased neonatal intensive care unit (NICU) leave. **Why it matters:** This move by the largest private employer in the U.S. sets a new benchmark for corporate benefits, influencing retention strategies and healthcare coverage decisions across the retail and logistics sectors. **Between the lines:** - Walmart will cover certain GLP-1 medications (Ozempic, Mounjaro) for Type 2 diabetes, but not for weight loss, requiring prior authorization. - Specialist care for serious conditions will expand through partnerships with Mayo Clinic and Cleveland Clinic. - New parents will receive up to 12 weeks of paid NICU leave, stackable with existing parental leave. **Staffing & HR impact:** These enhanced benefits are a direct investment in employee retention, aiming to reduce costly turnover in a competitive labor market and potentially influencing other large employers' benefits offerings. The strategic exclusion of weight-loss GLP-1 coverage highlights a nuanced approach to managing healthcare costs while still attracting and retaining talent. **The bottom line:** Walmart's proactive benefits overhaul signals a long-term strategy to stabilize its workforce and manage healthcare expenditures, offering a blueprint for other companies navigating similar challenges.

**The big picture:** Walmart is significantly expanding its employee health benefits in 2027, offering free GLP-1 medications and over 250 other prescription drugs, alongside enhanced specialized medical care. **Why it matters:** This move by the nation's largest private employer highlights a growing trend of companies investing in comprehensive health benefits to attract and retain talent, even as healthcare costs rise. **Between the lines:** - Walmart will provide free GLP-1 drugs for Type 2 diabetes and certain insulin products and inhalers. - The company is expanding its Centers of Excellence program for specialized care in conditions like MS and Parkinson's disease. - Premiums for Walmart's starting health insurance plan will increase by $1.50 per biweekly pay period. **Staffing & HR impact:** Such robust benefits packages can significantly boost employee retention and recruitment efforts, potentially reducing turnover costs and enhancing overall workforce well-being. HR departments will need to effectively communicate these complex changes to a large employee base. **The bottom line:** Walmart's investment signals a strategic shift towards more comprehensive employee welfare, setting a potential benchmark for other large employers.

**The big picture:** Walmart is making certain GLP-1 medications free for employees with Type 2 diabetes and expanding parental leave benefits, effective in 2027. **Why it matters:** This move signals a growing trend among large employers to manage healthcare costs and enhance benefits, directly impacting employee retention and overall workforce well-being. **Between the lines:** - Walmart will offer over 250 medications, including some GLP-1s, insulin, and inhalers, at no cost for employees with Type 2 diabetes. - The company is also adding up to 12 weeks of paid neonatal intensive care unit leave. - Health plan rates will increase by $1.50 per pay period, reaching $39.80, a smaller increase than the previous year. **Staffing & HR impact:** Enhanced health benefits and parental leave can significantly boost talent acquisition and retention efforts, potentially reducing turnover and improving employee satisfaction. This strategy could set a new benchmark for corporate benefits packages, influencing competitor offerings. **The bottom line:** Walmart's strategic investment in employee health and family support reflects a broader corporate effort to improve its employer brand and manage long-term workforce costs.